• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

长新冠:拟议的初级保健临床诊断和疾病管理指南。

Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management.

机构信息

Permanent Board of the Catalan Society of Family and Community Medicine (CAMFiC), 08009 Barcelona, Spain.

Primary Care Centre Les Corts, Consorci d'Atenció Primària de Salut Barcelona Esquerra (CAPSBE), 08028 Barcelona, Spain.

出版信息

Int J Environ Res Public Health. 2021 Apr 20;18(8):4350. doi: 10.3390/ijerph18084350.

DOI:10.3390/ijerph18084350
PMID:33923972
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8073248/
Abstract

Long COVID-19 may be defined as patients who, four weeks after the diagnosis of SARS-Cov-2 infection, continue to have signs and symptoms not explainable by other causes. The estimated frequency is around 10% and signs and symptoms may last for months. The main long-term manifestations observed in other coronaviruses (Severe Acute Respiratory Syndrome (SARS), Middle East respiratory syndrome (MERS)) are very similar to and have clear clinical parallels with SARS-CoV-2: mainly respiratory, musculoskeletal, and neuropsychiatric. The growing number of patients worldwide will have an impact on health systems. Therefore, the main objective of these clinical practice guidelines is to identify patients with signs and symptoms of long COVID-19 in primary care through a protocolized diagnostic process that studies possible etiologies and establishes an accurate differential diagnosis. The guidelines have been developed pragmatically by compiling the few studies published so far on long COVID-19, editorials and expert opinions, press releases, and the authors' clinical experience. Patients with long COVID-19 should be managed using structured primary care visits based on the time from diagnosis of SARS-CoV-2 infection. Based on the current limited evidence, disease management of long COVID-19 signs and symptoms will require a holistic, longitudinal follow up in primary care, multidisciplinary rehabilitation services, and the empowerment of affected patient groups.

摘要

长新冠可被定义为在 SARS-CoV-2 感染诊断后四周,持续出现无法用其他原因解释的体征和症状的患者。估计发病率约为 10%,且体征和症状可能持续数月。在其他冠状病毒(严重急性呼吸综合征(SARS)、中东呼吸综合征(MERS))中观察到的主要长期表现与 SARS-CoV-2 非常相似,且具有明确的临床相似性:主要为呼吸系统、肌肉骨骼和神经精神。全球范围内患者人数的增加将对卫生系统产生影响。因此,这些临床实践指南的主要目标是通过协议化的诊断流程,在初级保健中识别出具有长新冠体征和症状的患者,该流程研究可能的病因并建立准确的鉴别诊断。该指南是通过汇编迄今为止发表的少数关于长新冠的研究、社论和专家意见、新闻稿以及作者的临床经验,以务实的方式制定的。应根据 SARS-CoV-2 感染诊断后的时间,使用基于结构化的初级保健访视来管理长新冠患者。根据目前有限的证据,长新冠体征和症状的疾病管理将需要在初级保健中进行整体、纵向的随访、多学科康复服务以及受影响患者群体的赋权。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12cf/8073248/ee0fd9a2f2d5/ijerph-18-04350-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12cf/8073248/ee0fd9a2f2d5/ijerph-18-04350-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/12cf/8073248/ee0fd9a2f2d5/ijerph-18-04350-g001.jpg

相似文献

1
Long Covid-19: Proposed Primary Care Clinical Guidelines for Diagnosis and Disease Management.长新冠:拟议的初级保健临床诊断和疾病管理指南。
Int J Environ Res Public Health. 2021 Apr 20;18(8):4350. doi: 10.3390/ijerph18084350.
2
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19 disease.用于确定在基层医疗或医院门诊就诊的患者是否患有新冠病毒病的体征和症状。
Cochrane Database Syst Rev. 2020 Jul 7;7(7):CD013665. doi: 10.1002/14651858.CD013665.
3
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
4
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染:综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
5
Long-term complications after infection with SARS-CoV-1, influenza and MERS-CoV - Lessons to learn in long COVID?感染SARS-CoV-1、流感和中东呼吸综合征冠状病毒后的长期并发症——在长期新冠中可吸取的教训?
Infect Dis Now. 2023 Oct;53(8):104779. doi: 10.1016/j.idnow.2023.104779. Epub 2023 Sep 9.
6
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
7
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗或医院门诊环境中,出现症状和体征来确定患者是否患有 COVID-19。
Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD013665. doi: 10.1002/14651858.CD013665.pub2.
8
Biological, clinical and epidemiological features of COVID-19, SARS and MERS and AutoDock simulation of ACE2.新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征的生物学、临床和流行病学特征,以及 ACE2 的 AutoDock 模拟
Infect Dis Poverty. 2020 Jul 20;9(1):99. doi: 10.1186/s40249-020-00691-6.
9
Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.用于评估非住院轻中度 COVID-19 患者肠道微生物组调节的自然史和影响的虚拟化临床研究:一项随机、开放标签、前瞻性研究,平行组研究评估 KB109 对肠道微生物组结构和功能的生理影响:一项随机对照研究方案的结构化总结。
Trials. 2021 Apr 2;22(1):245. doi: 10.1186/s13063-021-05157-0.
10
Best Practices For Administering Monoclonal Antibody Therapy For Coronavirus (COVID-19) (Archived)冠状病毒(COVID-19)单克隆抗体疗法的最佳给药实践(已存档)

引用本文的文献

1
Consensus based recommendations for the management of post-COVID long-term sequelae (Long COVID): a regional perspective.基于共识的新冠后长期后遗症(长新冠)管理建议:区域视角
Front Med (Lausanne). 2025 Aug 6;12:1453167. doi: 10.3389/fmed.2025.1453167. eCollection 2025.
2
Development and content validation of the Long COVID/ post-acute sequelae of COVID-19 (PASC) patient-reported outcome (PRO) instrument.新冠长期症状/新冠急性后遗症(PASC)患者报告结局(PRO)工具的开发与内容验证
J Patient Rep Outcomes. 2025 Aug 20;9(1):105. doi: 10.1186/s41687-025-00942-w.
3
Agreement and Reliability Between Tele-Assessment and In-Person Assessment of the One-Minute Sit-to-Stand Test in Patients with Chronic Respiratory Diseases.

本文引用的文献

1
[Clinical characteristics of patients hospitalized with COVID-19 in Spain: Results from the SEMI-COVID-19 Registry].[西班牙新冠肺炎住院患者的临床特征:SEMI-COVID-19登记研究结果]
Rev Clin Esp. 2020 Nov;220(8):480-494. doi: 10.1016/j.rce.2020.07.003. Epub 2020 Jul 19.
2
Systemic and organ-specific immune-related manifestations of COVID-19.COVID-19 的全身性和器官特异性免疫相关表现。
Nat Rev Rheumatol. 2021 Jun;17(6):315-332. doi: 10.1038/s41584-021-00608-z. Epub 2021 Apr 26.
3
Symptom clusters in COVID-19: A potential clinical prediction tool from the COVID Symptom Study app.
慢性呼吸系统疾病患者一分钟坐立试验的远程评估与现场评估之间的一致性和可靠性
J Clin Med. 2025 Jul 16;14(14):5049. doi: 10.3390/jcm14145049.
4
One-minute sit-to-stand test reference values in people living at high altitudes.高海拔地区居民的一分钟坐立试验参考值。
Colomb Med (Cali). 2025 Mar 30;56(1):e2006674. doi: 10.25100/cm.v56i1.6674. eCollection 2025 Jan-Mar.
5
Long COVID's Hidden Complexity: Machine Learning Reveals Why Personalized Care Remains Essential.长期新冠的隐藏复杂性:机器学习揭示个性化护理为何至关重要。
J Clin Med. 2025 May 23;14(11):3670. doi: 10.3390/jcm14113670.
6
Living With Long COVID: Everyday Experiences, Health Information Barriers and Patients' Quality of Life.与新冠长期症状共存:日常经历、健康信息障碍与患者生活质量
Health Expect. 2025 Jun;28(3):e70290. doi: 10.1111/hex.70290.
7
SPACO+: a mixed methods protocol to assessing the effectiveness of an educative intervention in patients with Long Covid.SPACO+:一种评估针对长新冠患者的教育干预措施有效性的混合方法方案。
BMC Infect Dis. 2025 Apr 29;25(1):623. doi: 10.1186/s12879-025-10992-6.
8
Association of glycemic control with Long COVID in patients with type 2 diabetes: findings from the National COVID Cohort Collaborative (N3C).2型糖尿病患者血糖控制与长期新冠的关联:来自国家新冠队列协作研究(N3C)的发现
BMJ Open Diabetes Res Care. 2025 Feb 4;13(1):e004536. doi: 10.1136/bmjdrc-2024-004536.
9
One-minute sit-to-stand test: Reference values for the Chilean population.一分钟坐立试验:智利人群的参考值。
PLoS One. 2025 Jan 29;20(1):e0317594. doi: 10.1371/journal.pone.0317594. eCollection 2025.
10
A Review on Long COVID Screening: Challenges and Perspectives Focusing on Exhaled Breath Gas Sensing.长新冠筛查综述:聚焦呼出气气体传感的挑战与展望
ACS Sens. 2025 Mar 28;10(3):1564-1578. doi: 10.1021/acssensors.4c02280. Epub 2024 Dec 16.
COVID-19 症状群:COVID 症状研究应用程序的潜在临床预测工具。
Sci Adv. 2021 Mar 19;7(12). doi: 10.1126/sciadv.abd4177. Print 2021 Mar.
4
Persistent symptoms after acute COVID-19 infection: importance of follow-up.新冠病毒急性感染后的持续症状:随访的重要性
Med Clin (Engl Ed). 2021 Jan 10;156(1):35-36. doi: 10.1016/j.medcle.2020.08.003. Epub 2020 Dec 13.
5
Immune determinants of COVID-19 disease presentation and severity.COVID-19 疾病表现和严重程度的免疫决定因素。
Nat Med. 2021 Jan;27(1):28-33. doi: 10.1038/s41591-020-01202-8. Epub 2021 Jan 13.
6
Suggestions for lung function testing in the context of COVID-19.2019冠状病毒病背景下肺功能测试的建议。
Respir Med. 2021 Feb;177:106292. doi: 10.1016/j.rmed.2020.106292. Epub 2020 Dec 31.
7
6-month consequences of COVID-19 in patients discharged from hospital: a cohort study.新冠肺炎出院患者 6 个月的后果:一项队列研究。
Lancet. 2021 Jan 16;397(10270):220-232. doi: 10.1016/S0140-6736(20)32656-8. Epub 2021 Jan 8.
8
Prevalence and 6-month recovery of olfactory dysfunction: a multicentre study of 1363 COVID-19 patients.嗅觉功能障碍的患病率和 6 个月的恢复情况:1363 例 COVID-19 患者的多中心研究。
J Intern Med. 2021 Aug;290(2):451-461. doi: 10.1111/joim.13209. Epub 2021 Jan 5.
9
SARS-CoV-2 detected in olfactory neurons.在嗅觉神经元中检测到严重急性呼吸综合征冠状病毒2(SARS-CoV-2)
Nat Rev Neurol. 2021 Feb;17(2):63. doi: 10.1038/s41582-020-00449-6.
10
NICE guideline on long covid.英国国家卫生与临床优化研究所关于长期新冠的指南。
BMJ. 2020 Dec 23;371:m4938. doi: 10.1136/bmj.m4938.